Nova Patents
LT3086782T

Optimised pharmaceutical formula for the treatment of inflammatory changes of the esophagus

Abstract

This record has no abstract on file.

Term

8.2 yearsto projected expiry

Projected expiry 18 December 2034, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

63 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
13199278European Patent Office (EPO)A
13199278European Patent Office (EPO)A
2014078391European Patent Office (EPO)W
2014078391European Patent Office (EPO)W
13199278–––
EP20130199278–––
EP2014078391–––
WO2014EP78391–––

Members63

Family members, oldest first
DocumentOfficeKind
EP2886108A1European Patent Office (EPO)A1
CA2934009A1CanadaA1
WO2015097053A1World Intellectual Property Organization (WIPO)A1
HK1209362A1Hong Kong, ChinaA1
AU2014372739A1AustraliaA1
IL246172D0IsraelD0
CN105848648AChinaA
EP3086782A1European Patent Office (EPO)A1
US2016324772A1United States of AmericaA1
JP2017500361AJapanA
EA201600497A1Eurasian Patent Organization (EAPO)A1
ZA201604225BSouth AfricaB
US9867780B2United States of AmericaB2
EA029166B1Eurasian Patent Organization (EAPO)B1
UA117162C2UkraineC2
US2018185277A1United States of AmericaA1
EP3086782B1European Patent Office (EPO)B1
PT3086782TPortugalT
TR201815823T4TürkiyeT4
DK3086782T3DenmarkT3
LT3086782TThis recordLithuaniaT
SI3086782T1SloveniaT1
ES2694331T3SpainT3
HRP20181799T1CroatiaT1
IL246172AIsraelA
IL246172BIsraelB
EP2886108B1European Patent Office (EPO)B1
RS58112B1SerbiaB1
LT2886108TLithuaniaT
PL3086782T3PolandT3
DK2886108T3DenmarkT3
PT2886108TPortugalT
RS58543B1SerbiaB1
JP6522626B2JapanB2
HRP20190677T1CroatiaT1
SI2886108T1SloveniaT1
AU2014372739B2AustraliaB2
ES2716990T3SpainT3
HUE041911T2HungaryT2
HUE042009T2HungaryT2
CN105848648BChinaB
US10369100B2United States of AmericaB2
JP2019142931AJapanA
PL2886108T3PolandT3
US2019358155A1United States of AmericaA1
CA2934009CCanadaC
CY1121168T1CyprusT1
CY1121523T1CyprusT1
US10695291B2United States of AmericaB2
JP6757444B2JapanB2
US2020337997A1United States of AmericaA1
JP2020196753AJapanA
NZ721495ANew ZealandA
JP7009575B2JapanB2
US11382860B2United States of AmericaB2
EP2886108B2European Patent Office (EPO)B2
DK2886108T4DenmarkT4
HRP20190677T4CroatiaT4
FI2886108T4FinlandT4
PL2886108T5PolandT5
RS58543B2SerbiaB2
SI2886108T2SloveniaT2
ES2716990T5SpainT5